Investigation of blood leptin and adropin levels in patients with multiple sclerosis: A CONSORT-clinical study.

ABSTRACT:

Background

The effects of adipokines have been investigated in multiple sclerosis (MS) in the literature. Results are uncertain, and subgroups like adropin have not been previously studied. We primarily aimed to determine leptin and adropin levels in MS and their potential use as a biomarker.

Methods

This study was an experimental research. While 44 MS patients diagnosed according to McDonald criteria were included in the patient group, 40 people without MS diagnosis and risk factors took part in the control group. Demographic data, height, weight, body mass index, blood glucose, thyroid-stimulating hormone, alanine transaminase, aspartate transaminase, creatinine, low-density lipoprotein, leptin, adropin levels, presence of hypertension, diabetes mellitus, coronary artery d

SUBMITTER: Cinkir U 

PROVIDER: S-EPMC8448068 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature